发明名称 |
Oxadiazole compounds as urokinase inhibitors |
摘要 |
The present invention relates to novel compounds which inhibit urokinase-plasminogen activator (uPA), have a high bioavailability and can be administered orally, and to their use as therapeutic active substances for the treatment of disorders associated with urokinase and/or urokinase receptor, for example tumours and metastasis. The invention relates in particular to compounds containing oxadiazole groups.
|
申请公布号 |
US2009286837(A1) |
申请公布日期 |
2009.11.19 |
申请号 |
US20060991268 |
申请日期 |
2006.08.29 |
申请人 |
SPERL STEFAN;ZIMMERMANN JANA;KOCH KLAUS |
发明人 |
SPERL STEFAN;ZIMMERMANN JANA;KOCH KLAUS |
分类号 |
A61K31/225;A61K31/4245;A61P35/04;C07C69/34;C07D271/07 |
主分类号 |
A61K31/225 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|